finance.yahoo.com
·
Sep 9
Kazia (KZIA) Raises Approximately $40M in Gross Proceeds and Expands Paxalisib. Is the Capital Base Stronger than the Clinical Evidence?
Discussion
0 comments
Want to join the discussion?
Log in
or
create an account.
No comments yet. Start the discussion.